NIH Guide: Weekly Index for April 8, 2022

Funding Opportunities

• Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)
  (PAR-22-147)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
  (PAR-22-154)
  National Institute of Mental Health
  Application Receipt Date(s): January 5, 2023
• Alcohol Health Services Research (R01 Clinical Trial Optional)
  (PAR-22-156)
  National Institute on Alcohol Abuse and Alcoholism
  Office of Research on Women's Health
  Application Receipt Date(s): May 7, 2023
• Alcohol Health Services Research (R34 Clinical Trial Optional)
  (PAR-22-157)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): May 7, 2023
• Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
  (PAR-22-158)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): May 7, 2023
• Alcohol Treatment and Recovery Research (R34 Clinical Trial Required)
  (PAR-22-159)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): May 7, 2023
• Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
  (PAR-22-161)
  National Cancer Institute
  Application Receipt Date(s): November 7, 2024
• Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)
  (RFA-AI-22-020)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 1, 2022
• Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-028)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 29, 2022
• Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
  (RFA-CA-22-016)
  National Cancer Institute
  Application Receipt Date(s): September 27, 2022
• Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
  (RFA-CA-22-020)
  National Cancer Institute
  Office of Research on Women's Health
  Application Receipt Date(s): June 17, 2022
• SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
  (RFA-CA-22-025)
  National Cancer Institute
  Application Receipt Date(s): August 6, 2021
• Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required)
  (RFA-DA-23-002)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 11, 2022
• NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (RFA-DC-23-001)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): August 4, 2023
• A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)
  (RFA-EY-22-001)
  National Eye Institute
  Application Receipt Date(s): July 6, 2022
• Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18)
  (RFA-HS-22-001)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): June 17, 2022
• Diagnostic Centers of Excellence: Partnerships to Improve Diagnostic Safety and Quality (R18)
  (RFA-HS-22-008)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): June 9, 2022
• Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)
  (RFA-MD-22-006)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): May 31, 2022
• INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
  (RFA-OD-22-007)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 1, 2024
• Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)
  (RFA-OD-22-008)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)
  (RFA-OD-22-009)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): July 1, 2024
• Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
  (RFA-OD-22-010)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 1, 2024
• Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)
  (RFA-OD-22-011)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute of Environmental Health Sciences
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): May 31, 2022
• NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
  (RFA-RM-22-019)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): August 19, 2022